These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 29977628)

  • 1. A Case of Hyperacute Severe Thrombocytopenia Occurring Less than 24 Hours after Intravenous Tirofiban Infusion.
    Meghrajani V; Sabharwal N; Namana V; Elsheshtawy M; Topi B
    Case Rep Hematol; 2018; 2018():4357981. PubMed ID: 29977628
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Case report: reuse of tirofiban leads to very severe thrombocytopenia.
    Li Y; Qiu J; Gao Y; Li G
    Front Cardiovasc Med; 2023; 10():1130552. PubMed ID: 37273872
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Severe thrombocytopenia induced by tirofiban after percutaneous coronary intervention: a case report.
    Wang ZM; Wang B; Li YF; Chen B; Shen Q; Li DF; Wang LS
    J Med Case Rep; 2023 Oct; 17(1):430. PubMed ID: 37838704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A case of pseudothrombocytopenia after infusion of abciximab in vivo and anticoagulant-independent platelet clumping after rechallenge with abciximab in vitro.
    Kozak M; Dovc T; Rozman P; Blinc A
    Wien Klin Wochenschr; 2000 Feb; 112(3):138-41. PubMed ID: 10729966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin-induced thrombocytopenia: a case proven with rechallenge.
    Marraffa J; Guharoy R; Duggan D; Rose F; Nazeer S
    Pharmacotherapy; 2003 Sep; 23(9):1195-8. PubMed ID: 14524652
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Severe thrombocytopenia following tirofiban infusion.
    Panduranga P; Sulaiman K
    Indian J Pharmacol; 2011 Nov; 43(6):726-8. PubMed ID: 22144785
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abciximab-associated thrombocytopenia after previous tirofiban-related thrombocytopenia.
    Dorsch MP; Montague D; Rodgers JE; Patterson C
    Pharmacotherapy; 2006 Mar; 26(3):423-7. PubMed ID: 16503724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Acute profound thrombocytopenia associated with tirofiban: clinical approach to diagnosis and therapeutic management].
    Agnelli D; Ottani F
    G Ital Cardiol (Rome); 2008 Feb; 9(2):137-43. PubMed ID: 18383777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tirofiban-associated acute thrombocytopenia.
    Tuhta AG; Yeşildağ O; Köprülü D
    Acta Cardiol; 2006 Oct; 61(5):577-9. PubMed ID: 17117761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vancomycin-induced thrombocytopenia without isolation of a drug-dependent antibody.
    Ruggero MA; Abdelghany O; Topal JE
    Pharmacotherapy; 2012 Nov; 32(11):e321-5. PubMed ID: 23065779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probable tirofiban-induced thrombotic microangiopathy after stent thrombosis: a case report.
    Mattioli M; Paoli G; Cambò B; Bonura R
    Eur Heart J Case Rep; 2023 Jan; 7(1):ytad005. PubMed ID: 36713264
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II type 1 receptor blocker-induced immune thrombocytopenia: a case report.
    Patel DK; Bilkha N; Schnee D
    J Med Case Rep; 2013 Jul; 7():183. PubMed ID: 23856430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute profound thrombocytopenia associated with readministration of eptifibatide: case report and review of the literature.
    Russell KN; Schnabel JG; Rochetto RP; Tanner MC
    Pharmacotherapy; 2009 Jul; 29(7):867-74. PubMed ID: 19558261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vanishing platelets: rapid and extreme tirofiban-induced thrombocytopenia after percutaneous coronary intervention for acute myocardial infarction.
    Rahman N; Jafary FH
    Tex Heart Inst J; 2010; 37(1):109-12. PubMed ID: 20200641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sulfamethoxazole-induced thrombocytopenia masquerading as posttransfusion purpura: a case report.
    Nixon CP; Cheves TA; Sweeney JD
    Transfusion; 2015 Nov; 55(11):2738-41. PubMed ID: 26098194
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platelet inhibition by increased tirofiban dosing during primary coronary angioplasty for ST elevation myocardial infarction.
    Kralisz P; Dobrzycki S; Nowak K; Kochman W; Gajewska-Bachórzewska H; Gugała K; Mezyński G; Prokopczuk P; Zuk J; Korecki J; Poniatowski B; Musiał W
    Kardiol Pol; 2004 May; 60(5):459-67. PubMed ID: 15247961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Profound thrombocytopenia after abciximab administration in acute myocardial infarction and stent thrombosis following thrombocytopenia remission--a case report].
    Elikowski W; Rzeźniczak J; Słomczyński M; Psuja P
    Kardiol Pol; 2005 Jan; 62(1):44-7; discussion 48. PubMed ID: 15815778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged thrombocytopenia associated with procainamide in an elderly patient.
    Landrum EM; Siegert EA; Hanlon JT; Currie MS
    Ann Pharmacother; 1994 Oct; 28(10):1172-6. PubMed ID: 7841573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombocytopenia caused by abciximab or tirofiban and its association with clinical outcome in patients undergoing coronary stenting.
    Merlini PA; Rossi M; Menozzi A; Buratti S; Brennan DM; Moliterno DJ; Topol EJ; Ardissino D
    Circulation; 2004 May; 109(18):2203-6. PubMed ID: 15117843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abciximab-induced acute profound thrombocytopenia postpercutaneous coronary intervention.
    Golden T; Ghazala S; Wadeea R; Junna S
    BMJ Case Rep; 2017 Jul; 2017():. PubMed ID: 28710245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.